Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - February 2014


RoHS2 COMPLIANCE FOR MEDICAL DEVICES

11 Feb 2014 - 11 Feb 2014 - Webinar



Bookmark and Share


This will be a 2-3 hour webinar for representatives from medical device companies who are tasked with compliance to the upcoming Restriction of Hazardous Substances (RoHS) 2 directive deadline in July 2014. The directive reflects small, but important changes in definitions to EEE and the scope of materials which are now not allowed to be in new products coming to the market in Europe. NextLevel Pharma’s focused and interactive webinar will look to quickly answer the questions you may have regarding your products nature and it’s requirement for compliance, any possible exemptions that are available which may apply and learn from well-prepared device manufacturers how to quickly become compliant from both a product specific and a manufacturing / operational design perspective. Why This Event? • Learn from Hogan Lovell’s expert legal advice on what the directive means to you, if your products are in scope and what the consequences may be if you are not compliant. • Hear from Öko Institut, who assess and advise on RoHS 2 medical device exemptions for the European Commission, as to how and where exemptions exist and what is the application & exemption submission process. • Experience TÜV SÜD’s depth of expertise and solution-minded approach to achieving compliance with RoHS2. • Ask your questions to learn if this is applicable to your products or to simply confirm with confidence that your products are prepared and that nothing else needs to be done. To request the full agenda please follow this link: 

Further information
Scientific News
Microdroplet Reactors Mimic Living Systems
Researchers use microdroplets to study non-equilibrium reactions like those in living organisms.
NIH Researchers Identify Striking Genomic Signature for Cancer
Institute has identified striking signature shared by five types of cancer.
CRI Develops Innovative Approach for Identifying Lung Cancer
Institute has developed innovative approach for identifying processes that fuel tumor growth in lung cancer patients.
Envigo Rat Models Proven to be Susceptible to Intra-Vaginal HSV-2 Infection and Protectable
Scientific findings establish the effectiveness of new approach to investigate the protective effects of vaccine candidates and anti-viral microbodies and to study asymptomatic primary genital HSV-2 infection.
What do Banana Peels and Human Skin Have in Common?
Human skin and banana peels have something in common: they produce the same enzyme when attacked. By studying fruit, researchers have come up with an accurate method for diagnosing the stages of this form of skin cancer.
The Spice of Life
Scientists discover important genetic source of human diversity.
Cytoskeleton Crew
Findings confirm sugar's role in helping cancers survive by changing cellular architecture.
The Power of Three
Overlooked portion of cell “death receptor” critical in some cancers, autoimmune diseases.
Drug that Activates Innate Immune System Identified
Researchers from the institute have identified a drug, which is straightforward to synthesize and to couple to antigens that induce an immune response and may prove useful in the generation of vaccines.
Removing Race from Human Genetic Research
A group of scientists are urging their colleagues to take a step forward and stop using racial categories when researching and studying human genetics.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!